Methenamine Hippurate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alvogen Inc.. The primary component is Methenamine Hippurate.
Product ID | 47781-577_0bc637bb-cd50-9b86-a5c6-be5e000e07db |
NDC | 47781-577 |
Product Type | Human Prescription Drug |
Proprietary Name | Methenamine Hippurate |
Generic Name | Methenamine Hippurate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2010-05-03 |
Marketing Category | NDA / NDA |
Application Number | NDA016151 |
Labeler Name | Alvogen Inc. |
Substance Name | METHENAMINE HIPPURATE |
Active Ingredient Strength | 1 g/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2017-10-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA016151 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-10-23 |
Ingredient | Strength |
---|---|
METHENAMINE HIPPURATE | 1 g/1 |
SPL SET ID: | bc95972d-3db2-122a-0d1c-d7080c251445 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0115-1754 | Methenamine Hippurate | Methenamine Hippurate |
0955-1037 | Methenamine Hippurate | Methenamine Hippurate |
42571-332 | Methenamine Hippurate | Methenamine Hippurate |
43199-020 | Methenamine Hippurate | Methenamine Hippurate |
47781-577 | Methenamine Hippurate | Methenamine Hippurate |
50268-549 | Methenamine Hippurate | Methenamine Hippurate |
50742-142 | METHENAMINE HIPPURATE | methenamine hippurate |
60687-694 | Methenamine Hippurate | Methenamine Hippurate |
64720-139 | Methenamine Hippurate | Methenamine Hippurate |
65862-782 | Methenamine Hippurate | Methenamine Hippurate |
68151-0984 | Methenamine Hippurate | Methenamine Hippurate |
69315-210 | Methenamine Hippurate | Methenamine Hippurate |
30698-277 | HIPREX | Methenamine Hippurate |
30698-477 | HIPREX | Methenamine Hippurate |